Viewing Study NCT03499795

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:30 PM
Ignite Modification Date: 2026-01-27 @ 6:11 PM
Study NCT ID: NCT03499795
Status: COMPLETED
Last Update Posted: 2023-07-14
First Post: 2018-04-09
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2
Sponsor: Inovio Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anal Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None High-grade squamous intraepithelial lesions (HSIL) View
None Human papillomavirus (HPV) View
None HPV-16 View
None HPV-18 View
None Anal intraepithelial neoplasia 2 (AIN2) View
None Anal intraepithelial neoplasia 3 (AIN3) View
None Peri-anal intraepithelial neoplasia 2 (PAIN2) View
None Peri-anal intraepithelial neoplasia 3 (PAIN3) View